Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a special stretching technique help older adults with muscle loss stay steady on their feet?

NCT ID NCT07741786

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether adding proprioceptive neuromuscular facilitation (PNF) exercises—a technique that involves stretching and contracting muscles—to a standard exercise program improves balance and mobility in adults aged 65 and older with sarcopenia, a condition marked by age-related muscle loss. Participants are split into two groups: one doing conventional exercises alone and the other doing conventional exercises plus PNF, both for 10 weeks. Researchers measure changes in balance, walking ability, fear of falling, and mood to see if the added PNF makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Proprioceptive neuromuscular facilitation (PNF) exercises added to a conventional exercise program
What this could lead to
If PNF proves superior, it could become a recommended addition to exercise programs for older adults with sarcopenia, potentially reducing falls and preserving independence.
What could go wrong
This is a small trial (34 participants) and the results may not apply broadly. The added benefit of PNF over conventional exercise alone remains uncertain, and any exercise carries a small risk of injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Feb 2022

Finished

Aug 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 65 years or older. * Diagnosis of sarcopenia according to the European Working Group on Sarcopenia in Older People criteria. * Ability to participate safely in the prescribed exercise program. * Completion of the baseline clinical assessment. * Provision of written informed consent to participate in the study. Exclusion Criteria: * Parkinson's disease. * Previous stroke. * Multiple sclerosis. * Vestibular disorders or vertigo. * Other major neurological diseases that could affect balance, gait, mobility, or physical performance. * Severe musculoskeletal disorders that could independently affect balance, gait, mobility, or participation in exercise. * Uncontrolled cardiovascular disease. * Any medical condition that could preclude safe participation in the exercise program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sarcopenia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Facility Name: Uşak Training and Research Hospital

    Uşak, Uşak, 64100, Turkey (Türkiye)

  • Usak Training and Research Hospital, Physical Medicine and Rehabilitation Clinic

    Uşak, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.